Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 32 Colorectal Neoplasms 15 Small Cell Lung Carcinoma 8 Neoplasms 8 Stomach Neoplasms 7 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Solid Tumor 2 Neuroblastoma 2 Nasopharyngeal Carcinoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Wilms Tumor 1 Weight Loss 1 Somatostatinoma 1 Solid Tumor Cancer 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Refractory Solid Tumors 1

Interventions

Fulvestrant 5 Letrozole 4 exemestane 3 Capecitabine 3 Anastrozole 3 ribociclib 2 dalpiciclib 2 apatinib 2 Gemcitabine 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 pyrotinib 1 patritumab deruxtecan 1 palbociclib 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Trastuzumab 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Ga(III)-DOTATOC 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡